Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
This patient support community is for discussions relating to cancer, cancer staging, chemotherapy, hormonal therapy, radiation therapy, surgery, and tumor types.
Mood: April2 is feeling old and depressed. :( Someone come and talk to me and cheer me up. Journal Entry: "I'm doing a video series with my small gr..." [Read]
Mood: April2 is feeling old and depressed. :( Someone come and talk to me and cheer me up. Journal Entry: "I'm doing a video series with my small gr..." [Read]
Mood: April2 is feeling old and depressed. :( Someone come and talk to me and cheer me up. Journal Entry: "I'm doing a video series with my small gr..." [Read]
Tumor markers are molecules occurring in blood or tissue that are associated with cancer and whose measurement or identification is useful in patient diagnosis or clinical management.
CA 19-9 is the most sensitive and specific marker currently used in the diagnosis of pancreatic cancer. Its interpretation, however, can be limited in the presence of certain nonmalignant diseases that have been correlated with elevated serum levels of CA 19-9.
CA 19-9 upto <40 U/mL is the normal reference value. The mean normal value is 7 U/ml.
CA 19-9 is elevated primarily in patients with carcinoma of the gastro-intestinal tract.
The greatest usefulness of CA 19-9 is with pancreatic cancer. 65% of patients with pancreatic cancer will have CA 19-9 levels greater than 120 kU/L.
ref:http://www.sydpath.stvincents.com.au/tests/CA199.htm